Review of the antenatal and postnatal use of steroids

Indian Journal of Pediatrics

Volumn 81, Issue 5, 2014, Pages 466-472

  Bartholomew, Julie ^a   Kovacs, Lajos ^a   Papageorgiou, Apostolos ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

CLD; Corticosteroids; Prematurity; RDS

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; STEROID;

ADVERSE OUTCOME; ARTIFICIAL VENTILATION; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHRONIC LUNG DISEASE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG USE; FETUS LUNG MATURATION; GENDER; GESTATIONAL AGE; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG FUNCTION; LUNG RECEPTOR; MORTALITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; OXYGEN SUPPLY; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PLACENTAL TRANSFER; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRENATAL PERIOD; RACE; RECEPTOR BINDING; RECOMMENDED DRUG DOSE; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; REVIEW; TREATMENT DURATION; VENTILATED PATIENT; FEMALE; FETAL DISEASES; INFANT, NEWBORN, DISEASES; NEWBORN; PREGNANCY;

FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; STEROIDS;

EID: 84902283278     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-014-1376-9     Document Type: Review

References (45)

1. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth infants: The NICHD neonatal research network. Am J Obstet Gynecol. 1995;173:269-74.
2. Ballard PL, Ballard RA. Cytoplasmic receptors for glucocorticoids in the lung of the human fetus and neonate. J Clin Invest. 1974;53:477-86.
3. National Institute of Child Health and Human Development. Report of the consensus development conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. Bethesda: NIH publication no. 95-3784, 1994.
4. Murphy BEP, Clark SG, Donal IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol. 1974;118:538-41.
5. Liggins GC, Howie RN. The prevention of RDS by maternal steroid therapy. In: Gluck L, ed. Modern Perinatal Medicine. Chicago: Yearbook; 1974. pp. 415-24.
6. Papageorgiou AN, Desgranges MF, Masson M, Colle E, Shatz R, Gelfand MM. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: A controlled double-blind study. Pediatrics. 1979;63:73-9. (Pubitemid 9111203)
7. Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: Randomised clinical trials. BMJ. 2011;342:d1696.
8. Papageorgiou AN, Colle E, Farri-Kostopoulos E, Gelfand MM. Incidence of respiratory distress syndrome following antenatal betamethasone: Role of sex, type of delivery, and prolonged rupture of membranes. Pediatrics. 1981;67:614-7. (Pubitemid 11061277)
9. Ardila J, Le Guennec JC, Papageorgiou A. Influence of antenatal betamethasone and gender cohabitation on outcome of twin pregnancies 24 to 34 weeks of gestation. Semin Perinatol. 1994;18:15-8. (Pubitemid 24064620)
10. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynecol. 1990;97:11-25. (Pubitemid 20136124)
11. Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Am J Obstet Gynecol. 1989;161:628-33. (Pubitemid 19252773)
12. Kari MA, Hallman M, Eronen M, Teramo K, Viretanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo- controlled multicenter study. Pediatrics. 1994;93:730-6. (Pubitemid 24136104)
13. Israel EJ, Schiffrin EJ, Carter EA, Freiberg E, Walker WA. Prevention of necrotizing enterocolitis in the rat with prenatal cortisone. Gastroenterology. 1990;99:1333-8. (Pubitemid 20381867)
14. Moise AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics. 1995;95:845-50.
15. Clyman RI, Mauray F, Roman C, Rudolph AM, Heymann MA. Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2. J Pediatr. 1981;98:126-8. (Pubitemid 11184079)
16. Papageorgiou AN, Doray J, Ardila R, Kunos I. Reduction of mortality, morbidity, and respiratory distress syndrome in infants weighing less than 1,000 grams by treatment with betamethasone and ritodrine. Pediatrics. 1989;83:493-7. (Pubitemid 19092578)
17. Mitsiakos G, Kovacs L, Papageorgiou A. Are antenatal steroids beneficial to severely growth restricted fetuses? J Matern Fetal Neonatal Med. 2013;26:1496-9.
18. Schmand B, Neuvel J, Smolders-de Haas H, Hoeks J, Treffers PE, Koppe JG. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics. 1990;86:58-64. (Pubitemid 20198458)
19. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New Engl J Med. 1989;320:1505-10. (Pubitemid 19145801)
20. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000;83:F177-81.
21. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National institute of child health and human development neonatal research network. N Engl J Med. 2001;344:95-101.
22. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics. 1998;101:e7.
23. Shah PS, Sankaran K, Aziz K, Allen AC, Seshia M, Ohlasson A, et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: A cause for concern? J Perinatol. 2012;32:132-8.
24. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: Results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003;289:1124-9. (Pubitemid 37430326)
25. Jefferies AL. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatr Child Health. 2012;17:573-4.
26. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial. Pediatrics. 1991;88:421-7.
27. Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: A multicenter, international, randomized, controlled trial. Pediatrics. 2006;117:75-83. (Pubitemid 46050522)
28. Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: A systematic review. Neonatology. 2010;98:289-96.
29. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998;338:1112-8. (Pubitemid 28227481)
30. Kovacs LB, Davis GM, Faucher DJ, Papageorgiou AN. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr. 1998;87:792-8. (Pubitemid 28346085)
31. Vincer MJ, Allen AC. Double blind controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW < 1,500 grams) who are ventilator dependent at 4 weeks of age. Pediatr Res. 1998;43:201A.
32. Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PRF. Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child. 1992;67:1-4.
33. Shrivastava A, Lyon A, McIntosh N. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease. Eur J Pediatr. 2000;159:380-4. (Pubitemid 30243644)
34. Marinelli KA, Burke GS, Herson VC. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia. J Pediatr. 1997;130:594-602. (Pubitemid 27492651)
35. Werner JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992;120:286-91.
36. Brosnan PG. The hypothalamic pituitary axis in the fetus and newborn. Semin Perinatol. 2001;25:371-84. (Pubitemid 33140481)
37. Langhoff E, Ladefoged J. Relative immunosuppressive potency of various corticosteroids measured in vitro. Eur J Clin Pharmacol. 1983;25:459-62. (Pubitemid 14234278)
38. Moya FR, Becerra M, Leiva L, Sorensen RU. Effect of dexamethasone on leukocyte number and lymphocyte-blastogenic response to mitogen in infants with bronchopulmonary dysplasia. Clin Pediatr. 1993;32:185-8. (Pubitemid 23097151)
39. Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: A systematic review. Neonatology. 2010;98:217-24.
40. Watterberg KL, American academy of pediatrics. Committee on fetus and newborn. Policy statement - postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics. 2010;126:800-8.
41. Wilson-Costello D, Walsh MC, Langer JC, Guillet R, Laptokk AR, Stoll BJ, et al. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: Effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics. 2009;123:e430-7.
42. Kersbergen KJ, de Vries LS, van Kooij BJM, Isqum I, Rademaker KJ, van Bel F, et al. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. J Pediatr. 2013;163:666-71.
43. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lifetink AF, Lazeyras F, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics. 2005;116:1-7.
44. Dimitriou G, Greenough A, Giffin FJ, Kavadia V. Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. Eur J Pediatr. 1997;156:51-5. (Pubitemid 26425779)
45. Shah VS, Ohlsson A, Halliday HL, Dunn M. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev. 2012;5: CD001969.